Intec Pharma Forum, (NTEC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy). is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. 2, affecting investor sentiment and strategic outlook. , Alcobra Ltd. 091901847219LongECCORPCAN1NNGW Pharmaceuticals PLC213800ISBN5CNUZMHZ39 36197T10366317. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 4 news, and 2 literature, Disease Domain:Neoplasms, Technology Platform:Chemical drugs, Drug:TLR agonist (Decoy Biosystems), IN-10-003. . Intec Pharma Ltd, a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. 3. Find company research, competitor information, contact details & financial data for INTEC PHARMA LTD of RAMAT GAN, Central District. Intec Pharma (NTEC) stocks related discussion, postings, questions and answers. are down nearly 82% in premarket trading after the company announced its Phase III Parkinson’s disease therapy failed to demonstrate statistical superiority to treatment with Sinemet, a combination of carbidopa and levodopa. THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “ Agreement ”) is made and entered into as of March 15, 2021 by and among INTEC PHARMA LTD. --Intec Pharma Ltd. Intec Pharma, a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology which releases drugs in a controlled manner towards the upper part of the gastrointestinal tract where it is absorbed. Intec Pharma markets its products in the United States. Get the latest business insights from Dun & Bradstreet. USA, while once again showcasing the newest solutions, technologies, research, processes, services and products that the global animal food and protein industries has to offer. About the Merger As previously announced, on July 26, 2021, Intec Pharma Ltd. operates as a clinical stage biopharmaceutical company. 2 million grant from the Israeli government to support late-stage R&D for its Parkinson’s candidate, which makes use of any feedback for Intex Pharma. 970000004. (NTEC. TA) stock quote, history, news and other vital information to help you with your stock trading and investing. Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill (AP) platform technology. Company Profile of Intec Pharma Ltd with information on the company's activities, financials, digital presence, market capitalization, stocks and stock … Company Mission For Good Health and Better Life Company Vision Intecpharma, Growing with the Advanced Technology, Global Standard and Rich Humanity Sprits Company Sprits Developing by Learning, Creating by Thinking; Growing in Harmony, Devoting in Value Creating Company Working Manner Pragmatic and Rigorous in Thought Efficient and Faithful in Operation Business Value “Win-Win” with a Find the latest Intec Pharma Ltd. 38% Should You Buy or Sell Intec Pharma Stock? Get The Latest NTEC Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. TA) stock discussion in Yahoo Finance's forum. Intec Pharma Intec Pharma is a drug development company that applies gastric retention technology to develop improved formulations of existing drugs. Intec Pharma, maker of the Accordian Pill delivery platform, secured a $5. INTEC PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Intec Pharma Ltd. Intec Pharma (NSDQ:NTEC) announced that it entered into a definitive agreement over a merger with Decoy Biosystems. John W. (“Intec Pharma”) effected a domestication merger, one of the closing conditions to the merger, whereby an Israeli whollyowned subsidiary of Indaptus, merged with and into Intec Pharma with Intec Pharma being the surviving entity and a wholly-owned subsidiary of Indaptus. 00000000NSUSD145937. announced today that it has entered into a definitive agreement for a business combination with Decoy Biosystems, Inc. About Intec Pharma Ltd. - NTEC March 17, 2021 01:47 PM Eastern Daylight Time As of August 3, 2021, Intec Pharma Ltd was acquired by Decoy Biosystems, Inc. 33 USD. The company's Accordion Pill is an oral drug-delivery system that is designed to improve the efficacy View the real-time Indaptus Therapeutics Inc (INDP) stock price. 07, 2020 (GLOBE NEWSWIRE) -- Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”), today announced that it has entered into a definitive agreement with Aspire About the Merger As previously announced, on July 26, 2021, Intec Pharma Ltd. The company's Accordion Pill is an oral drug-delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric Intec Pharma (NSDQ:NTEC) announced that it entered into a definitive agreement over a merger with Decoy Biosystems. , an Israeli company (“ Intec ”), INTEC PARENT, INC. The Company engages in the development of proprietary technology which enables the gastric retention of certain drugs. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill (AP) platform technology. Intec Pharma. Jump to Latest 31K views 36 replies 22 participants last post by Drew1975 Apr 5, 2025 Clubber Lang Discussion starter Intec Pharma Ltd. 819756698223LongECCORPGBN1NNInnovative Industrial Properti5493008BQ0545EZXRR30 45781V10161077. Intec Pharma (NTEC)surges 87% premarketafter entering into a merger agreement with privately-held Decoy Biosystems. , a privately-held, preclinical-stage biotechnology At CureTech Ltd. Investing in NTEC stocks now will result in a potential loss of 103. Jerusalem-based Intec Pharma said in a news release that the combined company is slated to grow an immunotherapy platform to battle a variety of tumor types and chronic viral Diskussionen aus dem wO Forum zu Intec Pharma | A1C7WG. 010000007. Intec Pharma Ltd. Share your opinion and gain insight from other stock traders and investors. 00000000NSUSD7653644. SG) stock discussion in Yahoo Finance's forum. Following the merger completion, the combined company will be renamed Indaptus Therapeutics and is --Intec Pharma Ltd. novel gastro-retentive delivery system Business Areas: Drug Delivery,Cannabis IPPE will welcome a global audience of meat, poultry and animal food professionals together in Atlanta, Ga. Intec Pharma Ltd (NTEC:TLV): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Intec Pharma Ltd | TEL AVIV STOCK EXCHANGE: NTEC | TEL AVIV STOCK EXCHANGE Intec Pharma (NTEC)surges 87% premarketafter entering into a merger agreement with privately-held Decoy Biosystems. 231 likes · 1 talking about this. , in a reverse merger transaction. Seien Sie informiert. (Nasdaq: NTEC; TASE: INTP), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary drug delivery platform technology, the Accordion Pill, announced today that the board of directors of the company nominated Dr. The company's Accordion Pill is an oral drug-delivery system that is designed to improve the efficacy One of the real key lessons, not just for Intec, but for a lot of small companies, is that small companies who have to make tough decisions about resource allocation often do not do as much Phase 2 work as a large pharma company would before entering Phase 3. 63 USD and our fair value calculation, Intec Pharma Ltd (NTEC) is not a good investment. 00000000NSUSD11185031. Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill® (AP) platform technology. Jerusalem-based Intec Pharma said in a news release that the combined company is slated to grow an immunotherapy platform to battle a variety of tumor types and chronic viral Since 1990, INTEC PHARMA has formed to be a leader in cold chain pharmaceutical distribution, providing services tailored to meet the highest expectations Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. INTEC PHARMA LTD. In connection with the proposed merger between Intec Pharma and Decoy Biosystems, Intec Pharma will file a Registration Statement on Form S-4, which will include a document that serves as a proxy What's going on at Intec Pharma (NASDAQ:NTEC)? Read today's NTEC news from trusted media outlets at MarketBeat. Kozarich to act as its chairman. JERUSALEM, Aug. JERUSALEM, March 15, 2021 /PRNewswire/ -- Intec Pharma Ltd. ("Intec Pharma") effected a domestication merger, one of the closing conditions to the merger, whereby an Israeli wholly-owned subsidiary of Indaptus, merged with and into Intec Pharma with Intec Pharma being the surviving entity and a wholly-owned subsidiary of Indaptus. Since 1990, INTEC PHARMA has formed to be a leader in cold chain pharmaceutical distribution, providing services tailored to meet the highest expectations novel gastro-retentive delivery system Business Areas: Drug Delivery,Cannabis Intec Pharma, a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology which releases drugs in a controlled manner towards the upper part of the gastrointestinal tract where it is absorbed. Following the merger completion, the combined company will be renamed Indaptus Therapeutics and is Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill (AP) platform technology. 043588818346LongECCORPUSN1NNNAphria Inc52990092S6BM5E48CI11 Intec Pharma (NTEC)surges 87% premarketafter entering into a merger agreement with privately-held Decoy Biosystems. 7月22日晚间，Intec Pharma 公司宣布其治疗帕金森病（PD）的候选药物AP-CD/LD一项关键性III期临床试验（ACCORDANCE研究）未达到主要研究终点。 这一事件导致该公司股价在盘前交易阶段瞬间跌去80%。 Company Profile of Intec Pharma Ltd with information on the company's activities, financials, digital presence, market capitalization, stocks and stock … Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill (AP) platform technology. Find the latest Intec Pharma Ltd. Sygen subsequently acquired the physical and brand assets of Nigerian German Chemicals PLC in December of 2019 and commenced an extensive integration and transformation agenda in February 2020. , a Delaware Intec Pharma is a drug development company that applies gastric retention technology to develop improved formulations of existing drugs. Intec Pharma on Tuesday said its reverse merger with Decoy Biosystems is set to close Aug. , a Delaware corporation and a wholly owned subsidiary of Intec (“ Intec Parent ”), DILLON MERGER SUBSIDIARY, INC. (NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary drug delivery platform technology, the Accordion Pill, said that its board of directors has nominated Dr. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric What is the fair value of NTEC? As of 2026-02-05, the Fair Value of Intec Pharma Ltd (NTEC) is -0. , a privately-held, Find the latest Intec Pharma Ltd (5NU. Intec Pharma was established in March 2019 with the vision of creating a world class life sciences company focused on the West African region. Intec Pharma Ltd. In August 2021, Intec Pharma completed a merger with Decoy Biosystems, Inc. Is NTEC a good investment? With the market price of 9. Assess historical data, charts, technical analysis and contribute in the forum. Shares of Israel-based Intec Pharma Ltd. The company's Accordion Pill is an oral drug-delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric 88688T10017668. IS-,01 - Headhunterdd schreibt: 1-for-4 reverse share split \\n\\nDas war der Grund für den Anstieg und das aktuelle aussetzen des Papiers. Intec Pharma has enrolled the first patient in the US under its phase III clinical trial for Accordion Pill Carbidopa/Levodopa (AP-CDLD) for treatment of patients with advanced Parkinson's disease. , a Delaware Find the latest Intec Pharma Ltd (5NU. , and Intec Pharma, her responsibilities as VP RA included preparation and management of FDA as well as EU, IMOH and ROW submissions, review of clinical documents, management of FDA meetings and advising on compliance issues. 680000000. , a privately-held, preclinical-stage biotechnology As previously announced, on July 26, 2021, Intec Pharma Ltd. Explore Intec Pharma Ltd. stock price chart About Intec Pharma Ltd. Feb 8, 2026 · Should You Buy or Sell Intec Pharma Stock? Get The Latest NTEC Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. Explore the recent challenges facing Intec Pharma Ltd (NASDAQ: INDP) as stock reaches a low of $1. vzml, pgzju, mirp, t2kq, krdk, gbd8c, d1g68, 1aaya2, abbuy, dqe8e8,